Log-In
|
Home
|
E-mail Alerts
|
My Headlines
|
Portfolio
Upgrade to StreetInsider Premium - FREE TRIAL!
Join Free
SI Premium
Full Feed View
Headline View
Upgrade to SI Premium
Ratings Insider
Analyst Comments
Hot Analyst Comments $
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Credit Ratings
Downgrade News
Hot Downgrades $
New Coverage News
Hot New Coverage $
Upgrade News
Hot Upgrades $
More...
M&A Insider
Merger News
Hot M&A News $
Private Equity
Rumors $
Merger Arbitrage
2012's Top M&A Deals
Top 50 Takeover Targets
More...
EPS Insider
Earnings Calendar
Earnings News
Hot Earnings $
Guidance
Hot Guidance $
Conference Calls
Earnings History Search
More...
Dividend Insider
Dividend News
Special Dividends $
Stock Buybacks
Hot Stock Buybacks $
Stock Splits
More...
IPO Insider
IPO News
Recent IPOs
Upcoming IPOs
More...
Hedge Fund Insider
Hedge Funds News
More...
Partners
QUICK LINKS :
Upcoming Dividends
EPS Movers
Top Upgrades
Buffett's Stocks
*NEW SI App
Newsletters
Follow @Street_Insider
More on CELG
- Summary
- Chart
- Profile
- Historical
Data
- Earnings
- Ratings
- Holders
Financials
Income Statement
Balance Sheet
Cash Flow Statement
News
- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...
- 13Ds
- 13Fs
- 13Gs
- Analyst Comments
- Analyst EPS Change
- Analyst EPS View
- Analyst PT Change
- Commodities
- Conference Calls
- Contributors
- Corporate News
- Credit Ratings
- Dividends
- Downgrades
- Earnings
- Economic Data
- Equity Offerings
- ETFs
- FDA
- Fed
- Forex
- General News
- Hedge Funds
- Hot Buybacks
- Hot Comments
- Hot Corp. News
- Hot Dividends
- Hot Downgrades
- Hot Earnings
- Hot FDA News
- Hot Guidance
- Hot Hedge Fund News
- Hot Insider Trades
- Hot IPOs
- Hot List
- Hot M&A
- Hot Mgmt Changes
- Hot New Coverage
- Hot Upgrades
- Insiders' Blog
- IPOs
- Life Enjoyed
- Litigation
- Management Comments
- Market Check
- Momentum Movers
- New Coverage
- Option EPS Action
- Options
- Press Releases
- Private Equity
- SEC Filings
- Special Dividends
- Special Reports
- Stock Splits
- Technicals
- Trader Talk
- Trading Halts
- Upgrades
Celgene Corp (NQ:CELG)
Delayed:
122.58
-1.06 (0.86%)
Trade Now!
Previous Close
$123.64
52 Week High
$131.42
Open
$122.61
52 Week Low
$58.53
Day High
$123.71
P/E
37.26
Day Low
$121.66
EPS
$3.29
Volume
198,490
Friends, Peers and Foes
(?)
:
SWY
,
NFLX
,
GILD
,
BBY
,
MU
(more...)
ALERTS
|
RSS
All Recent
SI Reports
Press Releases
SEC Filings
Major News
May 23, 2013 07:33 AM
Celgene (CELG) Granted FDA Priority Review for ABRAXANE sNDA in Advanced Pancreatic Cancer
May 23, 2013 07:30 AM
Celgene Announces U.S. FDA Grants Priority Review for ABRAXANE® sNDA in Advanced Pancreatic Cancer
May 14, 2013 05:49 PM
Gene Therapy Company bluebird bio (BLUE) Files $86M IPO
May 10, 2013 08:15 AM
Acceleron’s ACE-536 Preclinical Data Presentation Selected for Best Abstract at 12th International Symposium on Myelodysplastic Syndromes
May 9, 2013 04:06 PM
NeoStem CEO's Letter to Shareholders
May 6, 2013 05:09 PM
Form 8-K CELGENE CORP /DE/ For: May 06
May 6, 2013 02:28 PM
Celgene (CELG) Unit Achieves Statistical Significance in PALACE 4
May 6, 2013 02:27 PM
Apremilast Achieves Statistical Significance for the Primary and Major Secondary Endpoints in Fourth Pivotal Phase III Study (PALACE 4) of Patients with Psoriatic Arthritis
May 1, 2013 04:10 PM
Form 4 CELGENE CORP /DE/ For: Apr 29 Filed by: KARSEN PERRY A
May 1, 2013 04:10 PM
Form 4 CELGENE CORP /DE/ For: Apr 29 Filed by: HUGIN ROBERT J
View All Articles
Apr 25, 2013 07:30 AM
Celgene Corp (CELG) Tops Q1 EPS by 2c
Jan 24, 2013 07:32 AM
Celgene Corp (CELG) Tops Q4 EPS by 1c
Jan 7, 2013 11:32 AM
Celgene (CELG) Issues FY13 Outlook; Guides Longer-Term Growth Expectations
Oct 25, 2012 07:34 AM
Celgene Corp (CELG) Tops Q3 EPS by 2c; Bumps Guidance Higher
Jul 26, 2012 07:32 AM
Celgene Corp (CELG) Beats Q2 EPS by 4c
Jun 21, 2012 07:34 AM
Application for Celgene's (CELG) New Indication for Revlimid Withdrawn
Apr 26, 2012 07:09 AM
Celgene Corp (CELG) Misses Q1 EPS by 5c; Reaffirms FY2012 Guidance
Jan 26, 2012 07:48 AM
Celgene (CELG) Reaffirms FY12 EPS, Revs Outlook
Jan 26, 2012 07:38 AM
Celgene Corp (CELG) Misses Q4 EPS by 1c, Sales Fall Just Short
Oct 27, 2011 07:35 AM
Celgene Corp (CELG) Tops Q3 EPS by 7c, Raises FY11 Guidance Above Street
View All Major News
May 23, 2013 07:33 AM
Celgene (CELG) Granted FDA Priority Review for ABRAXANE sNDA in Advanced Pancreatic Cancer
May 14, 2013 05:49 PM
Gene Therapy Company bluebird bio (BLUE) Files $86M IPO
May 6, 2013 02:28 PM
Celgene (CELG) Unit Achieves Statistical Significance in PALACE 4
Apr 30, 2013 07:27 AM
Jefferies Boosts Celgene (CELG) PT to $152 on Upcoming MM-020 Data
Apr 29, 2013 07:22 AM
FORMA Therapeutics, Celgene (CELG) Enter Protein Homeostasis Collaboration
Apr 26, 2013 07:23 AM
Celgene (CELG) Reports Receipt of Positive CHMP Opinion on REVLIMID for MDS
Apr 25, 2013 07:30 AM
Celgene Corp (CELG) Tops Q1 EPS by 2c
Apr 24, 2013 05:33 PM
Trading Radar for 04/25: Exxon, (XOM), Dow (DOW), 3M (MMM), Hershey (HSY), UPS (UPS), Expedia (EXPE) Report
Apr 22, 2013 02:55 PM
Notable 52-Week Highs and Lows of the Day 04/22: (HAS) (CELG) (RAD) High; (MHR) (BTU) Low
Apr 11, 2013 07:00 AM
Jefferies Lifts Price Target on Celgene (CELG) to $140 Following Survey
View All Reports
May 23, 2013 07:30 AM
Celgene Announces U.S. FDA Grants Priority Review for ABRAXANE® sNDA in Advanced Pancreatic Cancer
May 10, 2013 08:15 AM
Acceleron’s ACE-536 Preclinical Data Presentation Selected for Best Abstract at 12th International Symposium on Myelodysplastic Syndromes
May 9, 2013 04:06 PM
NeoStem CEO's Letter to Shareholders
May 6, 2013 02:27 PM
Apremilast Achieves Statistical Significance for the Primary and Major Secondary Endpoints in Fourth Pivotal Phase III Study (PALACE 4) of Patients with Psoriatic Arthritis
Apr 29, 2013 08:30 AM
Celgene Corporation to Webcast at Upcoming Investor Conferences and Analyst Day
Apr 26, 2013 07:22 AM
Oral Anti-Cancer Therapy REVLIMID® Receives Positive CHMP Opinion as Treatment for Patients with Form of Rare Blood Cancer Deletion 5Q Myelodysplastic Syndromes
Apr 25, 2013 07:29 AM
Celgene Reports First Quarter 2013 Operating and Financial Results
Apr 11, 2013 08:36 AM
The Vatican's Pontifical Council for Culture, NeoStem, The Stem for Life Foundation & STOQ International Host 2nd International Vatican Adult Stem Cell Conference
Apr 3, 2013 07:30 AM
Celgene Corporation to Announce First Quarter 2013 Results on April 25, 2013
Mar 26, 2013 08:15 AM
Acceleron Receives Two FDA Orphan Designations for ACE-536
View All Press Releases
May 6, 2013 05:09 PM
Form 8-K CELGENE CORP /DE/ For: May 06
May 1, 2013 04:10 PM
Form 4 CELGENE CORP /DE/ For: Apr 29 Filed by: KARSEN PERRY A
May 1, 2013 04:10 PM
Form 4 CELGENE CORP /DE/ For: Apr 29 Filed by: HUGIN ROBERT J
May 1, 2013 04:09 PM
Form 4 CELGENE CORP /DE/ For: Apr 29 Filed by: FOUSE JACQUALYN A
May 1, 2013 04:08 PM
Form 4 CELGENE CORP /DE/ For: Apr 29 Filed by: DRAKE RODMAN L
May 1, 2013 04:08 PM
Form 4 CELGENE CORP /DE/ For: Apr 29 Filed by: Daniel Thomas O
May 1, 2013 04:07 PM
Form 4 CELGENE CORP /DE/ For: Apr 29 Filed by: CASEY MICHAEL D
May 1, 2013 04:06 PM
Form 4 CELGENE CORP /DE/ For: Apr 29 Filed by: Alles Mark J
Apr 30, 2013 04:12 PM
Form 10-Q CELGENE CORP /DE/ For: Mar 31
Apr 25, 2013 08:40 AM
Form 8-K CELGENE CORP /DE/ For: Apr 25
View All Filings
Entities mentioned with
CELG
Earnings
|
View Related Stories »
Citi
|
View Related Stories »
JPMorgan
|
View Related Stories »
Jefferies & Co
|
View Related Stories »
Robert W Baird
|
View Related Stories »
UBS
|
View Related Stories »
Bank of America
|
View Related Stories »
Credit Suisse
|
View Related Stories »
Deutsche Bank
|
View Related Stories »
Notable Analyst Rating Changes
|
View Related Stories »
Morgan Stanley
|
View Related Stories »
Trading Radar
|
View Related Stories »
Standard & Poor's
|
View Related Stories »
RBC Capital
|
View Related Stories »
Barclays
|
View Related Stories »
Soleil Securities
|
View Related Stories »
Merrill Lynch
|
View Related Stories »
Merriman Curhan Ford
|
View Related Stories »
Needham & Company
|
View Related Stories »
Argus
|
View Related Stories »
Cowen & Co
|
View Related Stories »
Piper Jaffray
|
View Related Stories »
Goldman Sachs
|
View Related Stories »
Goldman Sachs Conviction Buy List
|
View Related Stories »
Lazard
|
View Related Stories »
Show More...
View All Entities